Search for Clinical Trial Results
Neurofibroma - 181 Studies Found
Status | Study |
Completed |
Study Name: Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Condition:
|
Active, not recruiting |
Study Name: Medical Treatment of "High-Risk" Neurofibromas Condition: Neurofibromatosis 1 Date: 2009-01-16 Interventions:
|
Active, not recruiting |
Study Name: How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem Condition: Neurofibromatosis Type 1 Date: 2012-06-21 |
Completed |
Study Name: Quality of Friendships in Children With Neurofibromatosis Condition: Neurofibromatosis Date: 2007-07-26 Interventions: Behavioral: Questionnaire Questionnaire about the patient's relationship with their best friend. |
Suspended |
Study Name: Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas Condition:
|
Completed |
Study Name: R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas Condition:
Date: 2006-06-19 Interventions:
|
Completed |
Study Name: Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas Condition:
Date: 2004-01-13 Interventions: Drug: Pirfenidone Pirfenidone orally as capsules three times a day approximately every 8 hours for cycle |
Active, not recruiting |
Study Name: Study of PEG-Intron for Plexiform Neurofibromas Condition: Plexiform Neurofibroma Date: 2006-11-02 Interventions: Drug: PEG-Intron |
Recruiting |
Study Name: Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas Condition: Plexiform Neurofibromas Date: 2014-06-25 Interventions: Drug: Imatinib Mesylate oral administration Other Na |
Terminated |
Study Name: Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1) Condition: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1 Date: 2011-05-27 Interventions: Drug: Everolimus (RAD001) oral daily dosing of tablet starting with 2.5 mg |